DomovABUS • NASDAQ
add
Arbutus Biopharma Corp
Predch. zatv. cena
4,36 $
Denný rozsah
4,32 $ - 4,40 $
Rozsah rokov
2,71 $ - 5,10 $
Trhová kapitalizácia
843,34 mil. USD
Priemerný objem
2,70 mil.
Cena/zisk
-
Dividendový výnos
-
Hlavná burza
NASDAQ
Informácie
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Generálny riaditeľ
Dátum založenia
2007
Zamestnanci
44
